Status:
COMPLETED
Mindfulness During COVID-19
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Migraine Disorders
Stress
Eligibility:
All Genders
Phase:
NA
Brief Summary
The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.
Detailed Description
The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.The investigators are interested in targeting patients with migraine, providers, faculty an...
Eligibility Criteria
Inclusion
- Any person interested in participating in the mindfulness session will be eligible to complete the pre/post surveys and participate in the mindfulness session.
Exclusion
- None
Key Trial Info
Start Date :
March 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2020
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04319445
Start Date
March 23 2020
End Date
July 28 2020
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States, 27157